Clinical trial
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population at an Outpatient Clinic: Velacur and Blood-based Novel Tests
NCT06218589 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Invasive Diagnostic Tests for MASLD in Pediatric Population at an Outpatient Clinic: Velacur and Blood-based Novel Tests
- Lead sponsor
- Emory University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 18, 2024
- Completion date
- February 28, 2027
- Enrollment
- 200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic dysfunction associated steatotic liver disease, non-alcoholic fatty liver disease (nafld)